616-006 — Опухоли. Новообразования. Бластомы. Хористомы. Гамартомы. О…

A Systematic Review of Clinical Outcomes and Technical Considerations: Endoscopic Spine Surgery for Primary Spinal Tumors MaryLourdes Andreu, Anshul Ratnaparkhi, Long Di, Robert Kamil, Khushi Shah · 2026

Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study Simon Renders, Maud Ngoya, Laurence de Leval, Hervé Finel, Irma Khvedelidze · 2026

Terahertz Imaging for Breast Cancer Detection in Animal Models: A Literature Review with Narrative Synthesis Maria Elena Niță, Daniela Roxana Matasariu, Mioara Matei, Ana Cazacu, Bogdan-Ionel Tamba · 2026

Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer Xin Wang, Ouying Yan, J Y Zhou, Feng Wen, Yali Shen · 2026

Knowledge and Clinical Practices of Primary Care Physicians Regarding Soft Tissue Sarcomas: A Descriptive Cross-Sectional Study Raquel Gracia Rodríguez, Esperanza Romero‐Rodríguez, Ignacio Jimena, Fernando Leiva‐Cepas · 2026

A SYSTEMATIC REVIEW OF BREAST CANCER: RECENT TRENDS IN DETECTION, THERAPY, AND PREVENTION: A REVIEW 1*Shivani C. Lavate, 2Sucheta S. Pawar, 3Priyanka Sonwalkar, 4Maithili Jadhav, 5Bhaghyashree Deshmane, 6Pranjali Mane, 7Sayali Potdar · 2026

A study of postoperative pathologic complete response (pCR) following neoadjuvant chemoimmunotherapy in limited-stage small cell lung cancer (LS-SCLC) Chunmao Wang, Han Ming, Zitong Wang · 2026

Parotid Oncocytomas Express the Glycoprotein Non-metastatic Melanoma Protein B (GPNMB): A Potential Link with Birt-Hogg-Dubé Syndrome Alberto Peraza-Labrador, Justin Bishop, Laura S. Schmidt, John Wright, W Marston Linehan · 2026

Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial Qihua Zou, Shenrui Bai, Liang Wang, Hongyan Tong, Dongfeng Zeng · 2026

FOXR2-Mediated CNS Neuroblastoma in a Pediatric Patient Treated With Multimodal Therapy Including Proton Craniospinal Irradiation: A Case Report Waseem Syed, Chetan Shah, Leticia Schaefer · 2026

Primary breast leiomyosarcoma—pathological challenges and immunohistochemical insights in diagnosing a rare tumor: a case report Ashwini Pitambra, Ashutosh Rath, Immanuel Pradeep, Krishna Ramavath, Chandramouli Ramalingam · 2026

Appendiceal Neuroendocrine Tumor Presenting as Acute Appendicitis: A Case Report Edgar A Flores García, Hector A Lopez Villicaña, Azael Lopez Lopez, José M Hinojosa Rodríguez, Oscar E Coronado Padilla · 2026

Review of Haematological Toxicities in Well-Differentiated Neuroendocrine Tumours: A Case Report and Comprehensive Review of the Literature David Gómez, Ramón Salazar, Paula Jiménez‐Fonseca, Ana Custódio, Beatriz Antón-Pascual · 2026

Urinary bladder cancer in dogs Ana Rita Teixeira Files, Isabel Cristina Ribeiro Pires · 2026

Surgical Interventions in Cancer Anand Gupta, Poorna T. Anish · 2026

SOAT1 expression associates with prognosis, immune environment and biochemical indicators in glioma Weihua Hu, Wulong Liang, Xuyang Guo, Fangyuan Wang, Zhou Jing · 2026

Peripheral T-Cell Lymphoma NOS: Current Management and Emerging Therapeutic Strategies S. Kessler, Milan Khealani, Aditi Singh, Juan Jose Chango Azanza · 2026

Pediatric acute lymphoblastic leukemia in the era of blinatumomab: from risk-adapted chemotherapy only to immunotherapy, including concepts of care Andishe Attarbaschi · 2026

Cardiac dysfunction during immune checkpoint inhibitor therapy: association with extracardiac immune-related adverse events R Mincu, Lena Lampe, Lars Michel, Amir A. Mahabadi, Adelina V. Mark · 2026

Tumor Microenvironment: Its Role in Cancer Progression and Metastasis Deepali Aggarwal, Shivani Sahu, Sonal Datta · 2026

Neoadjuvant retlirafusp alfa (anti-PD-L1/TGF-β bifunctional fusion protein) with or without chemotherapy in unresectable stage III non-small cell lung cancer: updated results from the phase 2 TRAILBLAZER trial Yi Pan, Xue‐Ning Yang, Qi Zhou, Y W Zhao, Guang Han · 2026

Optimising individualised treatment decisions for locally advanced thymoma: precision selection of minimally invasive surgery and postoperative adjuvant radiotherapy Xuyang Peng, Qi Zhang, Bin Huang, Jianyang Ding, Mingjiang Huang · 2026

Peripheral T-cell Lymphoma in Japan: Real-World Patient Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs Charles Dharmani, Oluwatosin Fofah, Pingping Qu, Zoe Jiang, Jingjian Wang · 2026

The future of neurosurgical oncology lies in cognitive neurosciences: understanding brain processing is much more valuable than surgical technology Hugues Duffau · 2026

Off-label prescribing in ophthalmology: a retrospective analysis Claudio Bucolo, Lucia Gozzo, Laura Terranova, Maria Rita Badagliacca, Giovanni Luca Romano · 2026

Multidisciplinary Treatment of Post-radiation Sarcoma in the Left Axilla Following Radiotherapy for Breast Cancer: A Case Report and Review of the Literature Christos Doudakmanis, Konstantinos Bouliaris, Alexis Terras, Stefania Kokkali, Georgios Agrogiannis · 2026

Social inequalities in return-to-work among colorectal cancer survivors in Germany Johannes Soff, Ibrahim Demirer, Nora Tabea Sibert, Clara Breidenbach, Nicole Ernstmann · 2026

Cadonilimab plus chemotherapy as first-line treatment in PD-L1-negative advanced non-small cell lung cancer: a phase II clinical trial Li Wang, Chuangzhou Rao, Q Wang, Kuofang Huang, Li Liu · 2026

Nanoparticle-based strategies targeting disulfidptosis, anoikis, and PANoptosis for enhanced cancer therapy Jiaquan Mao, Adel Habibul, Yu Bai, Sheng Xin, Jun Zhang · 2026

2D MoS2-conformal 3D-printed platform for dual-phototherapy and bone regeneration Jong Hwa Seo, Inho Choi, Hyun Lee, Seojoon Bang, Hyeong Seok Kang · 2026

MRNA-BASED VACCINES IN MELANOMA THERAPY: MECHANISMS, ADVANCES, AND CLINICAL PERSPECTIVES *Saher N. Kazi, Prof. Trupti V. Kadam, Prof. (Dr.) Avinash B. Darekar · 2026

LPAR4 mediates resistance to interferon-induced stress in soft tissue sarcoma Jin-Fen Xiao, Emily Ko, Ashley Smith, Roberta Piras, Annaliese Fowler · 2026

Genomic co-alterations and immune-related adverse events shape outcomes of thymic malignancies treated with immune checkpoint inhibitors Harold Nathan Tan, Hung Le, Khaoula Ben Haj Frej, Lei Kang, Stéphane Champiat · 2026

Collagen-derived biomarkers reveal distinct fibrotic responses among cancer-associated fibroblasts Annika Hettich, Morten A. Karsdal, Nicholas Willumsen · 2026

Quercetin suppresses the progression of HBV-associated hepatocellular carcinoma by modulating the EGFR signaling pathway Z Wang, Jinzhen Huang, Danping Huang, Rui An, Guangdong Tong · 2026

Identification of PI3K alpha inhibitors through large-scale virtual screening and integrated molecular modeling, biophysical characterization, and ADMET profiling Yahya Khan, Attiqa Naz, Asad Ullah, Gulesehra Mujib, Luqman Khan · 2026

Emerging treatment strategies for newly diagnosed diffuse large B-cell lymphoma Kana Miyazaki · 2026

HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-dependent HMGCR activation Futang Li, Ming Yang, Xinghao Sun, Liwen Chen, Dijie Zheng · 2026

The oral microbiome is associated with the diagnosis, prognosis and radiotherapy sensitivity of esophageal cancer Li Li, Lingling Li, Yuanyuan Yang, Chaoguan Wang, Zhen Lan · 2026

KYNU in macrophages contributes to the unique immune feature of LUAD via integrating single-cell and bulk RNA sequencing data: an exploratory analysis Jie Yao, Changshuai Zhou, Liren Ding · 2026

Preoperative electrolyte-based metabolic biomarkers for prognostic assessment in gastric cancer: a multicenter study W L Kong, Yì Wáng, Xuqin Wu, Kangjie Zhang, Xingyu Wang · 2026

Case Report: Granular cell tumor of the axillary tail mimicking node-positive breast carcinoma — two cases with imaging–pathology correlation Yuming Shao, Xu Yang, Shasha Song, Hao Lin, Jie Zhang · 2026

A case of locally advanced appendicular mucinous adenocarcinoma Suryalok Pratap Shah, Rahul Gautam, Aishwarya Bhalerao, Supreet Kumar, Alok Kumar Pandey · 2026

Neuroendocrine Tumors of the Gallbladder: A Multicenter Case Series and Systematic Literature Review Indicating Predominantly Non-Aggressive Tumor Behavior and a Common Association with Cholesterol Polyps and Cholesterolosis Alessandro Vanoli, Yue Xue, Atsuko Kasajima, Rebecca Ruffoni, Zeynep Tarcan · 2026

Development of a prognostic model for postoperative survival in appendiceal pseudomyxoma peritonei based on clinical indicators Jie Jiao, Feng Li, Qi Liu, Haitao Zhang, Guanying Yu · 2026

Infectious complications after CAR T-cell therapy: mechanisms, risk stratification, and prevention E Lee, J H Lee, Hye Ryeon Kim, Seok Jae Huh, Suee Lee · 2026

Guidelines for gut microbiota technology of the chinese anti-cancer association (2025 Edition) Qiang Wang, Zhi Guo, Qingming Wu, Xiaomei Wang, Mingxing He · 2026

BRAF-targeted therapy in non-melanomatous BRAF-mutant tumours: a systematic review of broad but histology-modulated efficacy Yael Lefkovits, Luke McLean, Mark R Middleton, David M Thomas · 2026

Formulation of 5-fluorouracil loaded chitosan-based nanoparticles and evaluation of its cytotoxic effects against MCF-7 human breast cancer cells Idongesit Aniekan Ekpo, Airemwen Collins Ovenseri, Abdulrahman Abdullateef, Burak Durmaz · 2026

Altered intestinal mucosal microbiota mediated pathways in cancer signaling pathway provide new insight in Bai Canhua aqueous extract for radiation-induced enteritis Tianhao Liu, XU Bo-yan, Yu-hao Niu, Sheng-yi Zhu, Haitao Zhang · 2026

CANCER CHEMOTHERAPY: CONVENTIONAL APPROACHES AND RECENT ADVANCES Dr. Virendra Kushwaha*, Dr. Pooja Agrawal, Dr. B. K. Shoraisham, Dr. Rishabh Gupta, Dr. Vivek Prajapati, Dr. Saroj Yadav, Dr. Anshuman Agrawal, Dr. Deepankar Tiwari · 2026

Outcomes and Complications Associated With 191 Carbon Fiber Pedicle Screws in Spinal Oncology Patients Marcus Selles, J Japa, Chukwuka Obiofuma, Lancelot Benn, Oliver Tannous · 2026

Upregulation of NFS1 and downregulation of GSDMD as prognostic biomarkers in acute myeloid leukemia: implications for diagnosis and therapeutic strategies Sara M. Radwan, Dina Mostafa, Rania A. Radwan, Hany A. Elghobary, Wesam R. Elghamry · 2026

Elevated ICAM5 as a promising predictor of poor prognosis in bladder cancer via EMT, immune microenvironment, and therapy resistance Xiaolong Chen, Zhen Wang, Yangsheng Rong, Zhiqiang Zhu, Zheng Peng · 2026

Orthopaedic Oncology in Contemporary Practice: A Comprehensive Review of Primary Bone Tumours, Metastatic Pathways, and Evolving Surgical Techniques Parishekh Paulraj Jawahar, Ravinandan H A, Utkarsh Mahera, Parampreet Singh Mundh, Jassim Rahiman K · 2026

EGFR Signaling in Canine Mammary Tumors: Molecular Mechanisms, Clinicopathological Correlations, Comparative Aspects with Human Breast Cancer, and Translational Opportunities F. Noor, H. Noor · 2026

Independent somatic TP53 mutations in blood and tumor mimicking Li-Fraumeni syndrome in a 94-year-old man Chuan Gao, Vikas Rai, Donna Wong, Zarina Yelskaya, Silvana Ostafi · 2026

CAR-T Cell-Derived Exosomes and Cancer Immunotherapy: Advancing Production and Delivery Through Biofabrication Mahmood Razzaghi, Mohammad Hossein Karimi, Jamshid Hadjati, Colin Collins, Mohsen Akbari · 2026

Patient Preferences in Decision-Making for Systemic Treatment of Early Breast Cancer: A Scoping Review Bianca Seiler, Dafne N. Sanchez, Nadia Maggi, Stefan Aebi, Beat Thürlimann · 2026

Emerging Oncolytic Viruses: Beyond Adenoviruses and Herpes Simplex Virus Santosh Chokkakula, Cheng-liang Yin, Bing Yang, Siomui Chong, Balaji Pathakumari · 2026

Exosomes in Cancer Biology: Emerging Biomarkers and Therapeutic Targets Marriam Ahmed, Chieh‐Wei Chang, Sundas Ijaz, Abdul Qadeer, Khalid J. Alzahrani · 2026

Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 study Ye Guo, Zhendong Li, L. Xue, Jinguan Lin, Song Qu · 2026

Real-world outcomes of immunotherapy in advanced NSCLC patients with comorbidities HH Hektoen, KM Tsuruda, MT Mæhlen, Å Helland, BK Andreassen · 2026

Reprogramming the Tumor Oncobiosphere: Bioactive Nanohybrid Materials for Reversing Therapeutic Pseudo-Resistance N. Sanoj Rejinold, Geun‐woo Jin, Jin‐Ho Choy · 2026

Epidemiology and Treatment Patterns of Stage III Resectable Melanoma Treated with Adjuvant Therapy: A Real-World Study Using the SNDS Database in France S. Monestier, S. Branchoux, Louis Chillotti, François-Emery Cotté, Clémentine Curioz · 2026

Emerging paradigms in nanostructured targeted drug delivery systems Anjum N. Hasnain, Darshan R. Telange · 2026

Tumor Immune Infiltration and Its Association with Immune-Active Tumor Phenotypes in Muscle-Invasive Bladder Cancer: An Integrative TCGA Analysis Onyekachi Anya, Ogbonna Chikere, Progress Asoluka, Helen Oletu, Oluchi Idenyi · 2026

GABRD promotes hepatocellular carcinoma progression via the IL-10RA/JAK2-STAT3 signaling axis Chengcheng Huang, Weiwei Liu, Zheng Wang, Yingling Liu, Zhenfei Bi · 2026

Engineering an AIEgen-based platform integrating CRISPR/Cas9 to remodel the tumor microenvironment and reinforce photo-immunotherapy against glioblastom Guanghong Luo, Fulong Ma, Yaoqiang Yang, Chenzi Yang, Xing Li · 2026

Immunotherapy response and resistance in cutaneous squamous cell carcinoma Annette M. Lim, Danny Rischin · 2026

Predictive value of serum biomarkers for survival in melanoma: a systematic review and meta-analysis Lili Gulyás, Fanni Adél Meznerics, Bence Szabó, Noémi Nóra Varga, Lajos Vince Kemény · 2026

PD-1+CD8+ T cell infiltration complements PD-L1 to predict first-line chemo-immunotherapy outcomes in advanced ESCC Qian Zhao, Shuping Cheng, Yiyu Meng, Butuo Li, Linlin Wang · 2026

Integrative Profiling of Metabolic CYP Expression, DNA Mutation Rates, and Immune Cell Infiltration for Survival Prognosis in Hepatocellular Carcinoma Mona Dawood, Axel Guthart, Edna Ooko, Ralf Weiskirchen, Thomas Efferth · 2026

Therapeutic potential of photoimmunotherapy in solid tumors expressing CD98 heavy chain Citra R.A.P. Palangka, Naoya Kondo, Ayaka Kanai, Hirofumi Hanaoka · 2026

Image-guided brachytherapy in patients with inoperable FIGO 2009 stage IVB endometrial cancer who were not candidates for palliative surgery A. Rovirosa, Yaowen Zang, Elaine Limkin, Piotr Wojcieszek, Magdalena Stankiewicz · 2026

Radiosensitizing effect of astaxanthin on radiation–induced cytotoxicity in breast cancer cells Bothaina AL- Awady, Abdel-Moneim Osman, Diana Hanna, Shereen El kiki, Ebtehal El-Demerdash · 2026

Carboxymethylated β-glucan from Pichia kudriavzevii M16: structural characterization and multifunctional bioactivity Belgin Güldeste, Zehranur Yüksekdağ, Berat Cinar‐Acar, Serap Nigdelioglu Dolanbay · 2026

Shared Care Offers an Effective Framework for Managing Tagraxofusp Treatment in Blastic Plasmacytoid Dendritic Cell Neoplasm Alexander Ambinder, Thomas W. LeBlanc, M. Yair Levy, Ami B. Patel, James McCloskey · 2026

Efficacy and safety of PD-1 inhibitors in recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis Abdullah Alabbasi, Muhanad Alzahrani, Ziyad Alzahrani, Faris Sultan, Maha Alqahtani · 2026

Standard or Modified Gemcitabine Plus Nab-Paclitaxel (GnP) in the First-Line Treatment of Patients with Metastatic Pancreatic Adenocarcinoma (MPA): A Single-Center Analysis Victor Hugo Fonseca de Jesus, Francisco de Assis Maia, Cícero Gonzaga Santos, Tiago Cordeiro Felismino, Marcos Pedro Guedes Camandabora · 2026

Thromboembolic disease and hemostatic alterations in tumor-bearing dogs – A narrative review P. Pazzi, Annemarie T. Kristensen · 2026

Endometrial Stromal Sarcoma: A Rare Tumor Case Report Trupti Radkar, Savita Somalwar, Anuja Bhalerao · 2026

Evolving Concepts in Salivary Duct Carcinoma: A Narrative Review Marvin C. Masalunga, Patrick J. Bradley, Carla van Herpen, Toshitaka Nagao, Göran Stenman · 2026

Adnexal Masses: Diagnostic Quagmires to Miraculous Resolutions: A Case Series Pallavi Verma, Shivendra K Sinha, Natasha Dogra, Rahul Dudhal, Aabhas Mishra · 2026

Vitiligo-Like Depigmentation in Nivolumab-Treated Nodular Melanoma: A Paradoxical Clinical Course Frida M Ortega Garcia, Alejandra Gonzalez Uribe, Diana S Blanquet Campos, Martha A Aceves Villalvazo · 2026

Revisiting multi-nodal radiomics with advanced feature learning for lymphoma classification: a multi-center study Reza Karimzadeh, Setareh Hasanabadi, Maryam Cheraghi, Mehrdad Bakhshayesh Karam, Hossein Arabi · 2026

Laser-based therapies in the management of non-melanoma skin cancers: a narrative review Francesco Russano, Davide Brugnolo, Luigi Dall’Olmo, Francesco Callegarin, Paolo Del Fiore · 2026

A histopathologically verified dataset of magnifying narrow-band imaging endoscopy for classifying the gastric precancerous cascade Faguang Wang, Wanying Liao, Hengjie Su, Louzhe Xu, Huadan Xue · 2026

Metformin sensitizes esophageal squamous cell carcinoma to Vγ9Vδ2 T cell-mediated cytotoxicity by upregulating BTN3A1 and BTN2A1 Zishan Yang, Yadi Liu, Yixuan Han, Lijun Tan, Suli Wang · 2026

Multi-dimensional profiling of lactylation-related signatures for prognostic and therapeutic insights in bladder cancer Hongjun Zhao, K B Li, H Xu, Junhao Liao, Chubiao Zhuo · 2026

Oral manifestations and dental management in patients undergoing CAR-T cell therapy: a retrospective observational study Fernanda de Paula Eduardo, Luiza Deitos Menti, Mariana Henriques Ferreira, Danielle Lima Corrêa de Carvalho, Cristina de Paula Novaes · 2026

cPLA2α inhibition potentiates anti-PD-1 immunotherapy in lung adenocarcinoma via remodeling tumor microenvironment Ran Zuo, Yuchao He, Y S Wu, Huien Yang, Y L Wang · 2026

Exploring the functional role of XIST in breast cancer from mechanisms to clinical implications Nada I. Zyada, Mahmoud M. Kamel, Emad M. Elzayat, Abdel Hady A. Abdel Wahab · 2026

Moracin M inhibits EV71 infection primarily by blocking viral attachment to host cells YinYing Zhu, Qian Peng, Lu Hu, Weiling Li, Yingying Shi · 2026

Therapeutic potential of targeting macrophage polarization in metastatic gastric cancer: a review on core mechanisms and clinical progress Ningning Gong, Guanmin Qin, Junxia Sun, Shiying Shen, Xinxing Zhang · 2026

Old tale new admirers, cetuximab maintenance in metastatic colorectal cancer: a systematic review and meta-analysis Yici Yan, Zhenyi Lin, Jing Yuan, Weidong Gao, Chenxu Jiao · 2026

Efficacy and mechanisms of immune checkpoint inhibitors in late-stage EGFR-mutated non-small cell lung cancer following targeted therapy resistance Jiling Niu, Yì Wáng, Zongkai Liu, Yunxuan Si, 刘寨东 · 2026

Mucinous ovarian carcinoma in four teenage girls with fatal outcomes Lisa Feinstein · 2026

Case Report: Inflammatory myofibroblastoma of the right forearm in an adult male: a clinical report Lanlan Li, Xiang Chang, Zhichao Hu, Min Wang, Xiaoguang Huo · 2026

Report of a case of renal hilum Castleman disease complicated with Paget’s disease of the breast Weidong Yang, Hui Li, Dan Shen, Deqiang Gu, Shichao Song · 2026

Participant-Reported Preference for Pembrolizumab Administered Subcutaneously or Intravenously: A Randomized, Open-Label, Phase II Study Ignacio A. Casarini, Dariusz M. Kowalski, Christian Caglevic, Burçak Karaca Yayla, Ahmet Taner Sümbül · 2026

Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis J Wang, Yajuan Gao, N Nora Bennani, Yun Kyoung Tiger, Arushi Khurana · 2026

Leveraging the bacteria for enhanced cancer immunotherapy: from a perspective of synthetic biology Xing Liu, Haitao Zhang, Renchun Du, Zixu Liu, Yunyun Ren · 2026

Real-world outcomes of second-line pembrolizumab in urothelial carcinoma: a multicenter analysis from the Campania Oncological Network (ROC) Rosa Tambaro, Gabriele Calvanese, Andrea Muto, Luigi Formisano, Giuseppe Di Lorenzo · 2026

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis, Alison Stopeck, Jeri Matera · 2004

Interaction of PEGylated gold nanorods with HIF-1α/Ki-67 in inhibiting immunosuppression and arresting cancer proliferation in murine fibrosarcoma Nabanita Maity, Santu Ghosh, Kasturi Bhattacharjee, Yashmin Choudhury, Malaya Ghosh · 2026

Redefining the Treatment Landscape of Advanced Endometrial Cancer in the Era of Immunotherapy and Precision Oncology Martina Cassaniti, Ilaria Morelli, Anna Chiara Boschi, Simona Scodes, Giuseppe Comerci · 2026

Rarity Within Rarity: Complete Response to Chemoimmunotherapy in a Patient with Polymerase epsilon ( POLE)-Mutated locally advanced Jejunal Carcinoma Michele Prisciandaro, F Morano, Davide Citterio, Maria Flores Reyes, Marco Barella · 2026

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics Hee Jung Kim, H J Lee, Jin Hong, Daechan Park · 2026

Molecular tumor board availability and organization in sarcoma referral centers in Italy: are we on the right track? Concetta Elisa Onesti, Beatrice Casini, Annarosaria De Chiara, Valentina Fausti, Roberto Luksch · 2026

Case Report: Neuromyelitis optica spectrum disorder associated with gastric cardia and pancreatic cancers: clinical features and oncological implications Xiaoshan Wei, Kun Yuan, Wei Sang, Hongwei Zhang, Yidi Qin · 2026

Long-term toxicity of tandem radioligand therapy using [90Y]Y/[177Lu]Lu-DOTA-TATE in neuroendocrine tumors: a polish multicenter experience with 20-year follow-up Maciej Kołodziej, Anna Zemczak, Kacper Pełka, Dariusz Pawlak, Katarzyna Jozwik-Plebanek · 2026

Synchronous primary HPV-associated squamous cell carcinomas of the cervix and fallopian tube: a case report Juan Lu, Changqian Chen, Yanfang Bai, Min Kang · 2026

Multifaceted mechanisms by which environmental endocrine-disrupting chemicals promote cancer progression: crosstalk among carcinogenesis, immunity, and metabolic reprogramming: narrative mini-review Aoran Du, QiWei Yang, Lin Yu, Yishan Peng, Tao Huang · 2026

Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database Yang Yang, Fang Wang, Weijia Tong, Xinglan Lu, Feng Zhao · 2026

Research progress on the application of dual energy CT in gastric diseases Lin-na Wu, Xinyu Dai, Li-juan Wei · 2026

Diagnostic utility of FAPI PET/CT in radioiodine-refractory thyroid cancer and TENIS syndrome: a systematic review Akram Al-Ibraheem, Saad Ruzzeh, Ahmad Al-Muhtaseb, Ahmed Saad Abdlkadir, Serin Moghrabi · 2026

Orbital Myeloid Sarcoma Masquerading as Orbital Cellulitis: A Diagnostic Challenge in an Adult Patient Rahisha Maskey, Sharan Thapa, Oliver W Spencer, Zoe Avila · 2026

Mesenchymal transitions reduce lamin A expression and nuclear stiffness to enhance confined migration in glioblastoma Landon Teer, Neha Anil, Dominic Armagno, Bradley Mahaffey, Sihan Sun · 2026

CERVICAL CANCER: A MULTIDIMENSIONAL REVIEW OF MOLECULAR PATHOGENESIS, DIAGNOSTIC CHALLENGES, AND EMERGING THERAPEUTIC STRATEGIES Sneha S., Sruthi S., J. Anbu*, Sadhana Goswami · 2026

Heterogeneous Phenotype of Acute Leukemia with EWSR1 or FUS Gene Rearrangements Yanna Ding, Jinjun Cheng · 2026

Self-managed non-pharmacological interventions for post-treatment upper limb dysfunction rehabilition among breast cancer survivors: A systematic review Li Jinqiu, Jing-Yu (Benjamin) Tan, Tao Wang, Haiying Wang, Mengyuan Li · 2026

Role of thermal ablation in management of pulmonary tumors Ahmed M. M. O. Elqousy, Wahid H. Tantawy, Mohamed Sobhi, Haytham M. Nasser · 2026

My Life as a “Theranostician”: A commentary on the evolution of theranostics Rodney J. Hicks · 2026

Epidemiology of Childhood Cancer and Cancer Predisposition Syndromes (CPSs): A 20-Year Single-Center Cohort from the Greater Poland Region Gabriela Telman, Adrian Guźniczak, Patrycja Sosnowska‐Sienkiewicz, Danuta Januszkiewicz‐Lewandowska · 2026

Technical and clinical recommendations for [¹⁸F]FDOPA PET/CT in oncologic applications F Lanfranchi, Tiziana Lanzolla, Ilaria Ravelli, Annachiara Arnone, Davide D’Arienzo · 2026

Identification and validation of palmitoylation-associated biomarkers in major depressive disorder Xin Wang, Xiajin Ren, Ying Bai · 2026

Oncological outcome and immune-checkpoint-blockade-induced toxicities in patients with cervical cancer – a Norwegian real-world cohort Katharina Bischof, Keira Matallah Fredriksen, Maren Bjørnstad, Mari Bunkholt Elstrand, Brynhildur Eyjólfsdóttir · 2026

Metachronous Colorectal Carcinomas and Pancreatic Metastasis in Clinically Suspected Lynch Syndrome: An 18-Year Oncologic Course Manana Jikurashvili, Giorgi Narimanishvili, Ilya Gotsadze, Armaz Mariamidze, David Chechelashvili · 2026

GASTRIC LIPOSARCOMA: A CASE REPORT MARİYA MAŞTA, Haşim Köken, Sertaç Ata Güler, Turgay Şimşek, Enes Şahin · 2026

Intrahepatic Cholangiocarcinoma: The Weight of History Telma Costa Cabral, Ana Rita Ambrósio, Bruno Miguel Silva, Isménia de Oliveira, Hugo Pêgo · 2026

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours Maria A. Smolle, Florian A. Wenzl, Minna K. Laitinen, Lee M. Jeys, A Leithner · 2026

Recurrence Risk of Differentiated Thyroid Cancer Treated with Total or Hemithyroidectomy. Systematic Review and Meta-analysis Arnoldo Piccardo, Francesco Fiz, Gianluca Bottoni, Giorgio Treglia, Pierpaolo Trimboli · 2026

Information and support needs of childhood, adolescent, and young adult cancer survivors (CAYACS) across europe and associations with patient activation and health-related quality of life: Results from the e-QuoL project Anne Maas, Valeriia Balaeva, Maëlle de Ville de Goyet, Jelica Predojević, Jelena Roganovic · 2026

Unraveling the immune microenvironment in primary CNS lymphoma Sven Lorenzen, Vanja Zeremski, Mirjeta Berisha, Dimitrios Mougiakakos, Tobias R. Haage · 2026

Primary central nervous system lymphoma and tumefactive demyelinating lesions in multiple sclerosis: a retrospective observational cohort study Yushan Chen, Lvying Shen, ShaoQiang Chen, ShunYong Zheng, Jianmin Xie · 2026

Efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced esophagogastric junction or gastric cancer: a systematic review and meta analysis Xiumei Ma, Wei Guo, Jialin Sun, Yanyan Liang, Chuan Yao · 2026

Exploratory plasma ctDNA genomic biomarkers identified by whole-exome sequencing and a novel bioinformatics pipeline in advanced driver-negative NSCLC Luis Posado-Domínguez, Álvaro López-Gutiérrez, Edel del Barco Morillo, Juan Carlos Redondo-González, Marco Hernández-Pérez · 2026

Atypical Presentation of Classical Hodgkin Lymphoma as Superior Vena Cava Syndrome With Paraneoplastic Eosinophilia and Rash: A Case Report Pragnesh D Patel, Sowmya Yamarthy, Devon Thorpe, Julianne Esguerra, Ashish Shah · 2026

An Unclassifiable Malignant Ovarian Germ Cell Tumor With Focal Choriocarcinoma-Like Features: A Case Report With Diagnostic Ambiguity and Adjuvant Treatment Considerations Tadahisa Takeuchi, Hiroyasu Nakajima, Natsuko Hirose, Hachidai Hirakawa, Takahiro Kusaba · 2026

High Serum IgA Identifies Poor Responders to Immune Checkpoint Inhibitors in Patients with Unresectable Esophageal Squamous Cell Carcinoma K Torii, Akimitsu Iizuka, Dai Shimizu, Koki Nakanishi, Chie Tanaka · 2026

Pan-cancer single-cell atlases of mouse and human tumor-associated dendritic cells Aarushi A. Caro, Daliya Kancheva, Éva Hadadi, Bram Boeckx, Clint De Nolf · 2026

Biology Over Imaging: Duodenal Adenocarcinoma Recurrence Presenting as a Pancreatic Head Mass in Lynch Syndrome Evangelia Florou, Memoona Mukhtar, Muhammad Sarmad Mukhtar, Rohit Sasidharan, Parthi Srinivasan · 2026

Gamma-aminobutyric acid affects the tumor microenvironment and angiogenesis, promoting breast cancer progression Hui Wang, Jingxia Bao, Danfeng Lin · 2026

Tipping the balance: NRF2’s dual role in ferroptotic fate Izadora de Souza, Ana Beatriz da Silva Teixeira, Ancély Ferreira dos Santos, José Pedro Friedmann Ângeli, Clarissa Ribeiro Reily Rocha · 2026

Apatinib enhances anti-PD-1 efficacy by inhibiting Exo70-mediated exosome secretion in pMMR/MSS colorectal cancer Lingying Zhao, Chunyi Gao, Xiaoxue Qiao, Fanzhuoran Lou, Bowen Zheng · 2026

Surgery-Based Salvage for Locoregional Recurrent Salivary Gland Carcinoma: Comparative Survival Evidence from a Systematic Review and Meta-analysis Gene Huh, Jeong Wook Kang, Geun‐Jeon Kim, Jeong-Yeon Ji, Jooin Bang · 2026

Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasion Lily Keane, Martin Škandík, Mercedes Posada-Pérez, Raj Bose, John Desito · 2026

Imaging diagnosis of cystic intraparenchymal brain neoplasms Sonoko Oshima, Yasutaka Fushimi, Sachi Okuchi, S NAKAJIMA, Akihiko Sakata · 2026

Acylglycerol kinase contributes to cell proliferation by activating NF‑κB signaling pathway in pancreatic cancer Kunkun Han, Qianyun Zhang, Shengnan Gao, Jigang Zhang, Mei Xiao · 2026

AI-driven text mining of the female reproductive system: enabling multiscale biomedical modeling and personalized medicine G S Lee, Jeehyo Jeon, Sharon Jeeho Ham, Sieun Shin, Seo Yeon Kim · 2026

Autophagy impairs the sensitivity of Ewing sarcoma cells to PARP inhibitors Julia Clausen, Daniela Kocher, Hauke M. Schadwinkel, Sabine Becker, Till Milde · 2026

Elucidating the role of JAK/STAT signalling in polycythaemia vera and essential thrombocythaemia using proteomics Amy Kathryn Grayson · 2026

Examining the role of novel lignan compounds as anti-leukaemia agents Thomas Wainwright · 2026

NRG-GY036: A phase III trial of one vs. two years of maintenance olaparib, with or without bevacizumab, in patients with BRCA1/2 -mutated or homologous recombination deficient (HRD+) ovarian cancer following response to first line platinum-based chemotherapy. Liu Y, Austin Miller, Kathleen N. Moore, Joyce F. Liu, Heather A. Lankes · 2026

GraphTME: graph-based framework for predicting immunotherapy response by interpreting tumour microenvironment interactions using spatial transcriptomics Hoyeon Jeong, Junghan Oh, Yoon-La Choi · 2026

Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19 Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, Martin Spahn, Lukas Bubendorf · 2026

Strategies for engineering biomimetic lipoproteins to improve drug delivery efficiency and tumor therapy Yuchen He, Naibo Yin, Zhiwen Zhang, Guo‐Liang Lu, Jingyuan Wen · 2026

Circulating Tumor Cells in the Blood Microenvironment: Survival Mechanisms and Metastatic Potential Dong Geon Kim, Jee Young Sung, Yong-Nyun Kim · 2026

Mitochondrial Metabolic Reprogramming in Colorectal Cancer-Associated Fibroblasts: An Up-to-Date Review Ying Li, Dipanjan Chanda, Seong-Woo Jeon, Jae-Han Jeon, Min-Ji Kim · 2026

POLYSACCHARIDE-BASED TREATMENT APPROACHES FOR COLORECTAL CANCER Atufa Fatima, Ankita Tiwari, Kumud Madan · 2026

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer Karolina Weiner‐Gorzel, Lynda McSorley, Janice M. Walshe · 2026

Correlation between preoperative T-cell receptor profile characteristics and postoperative pathological stage/treatment response in non-small cell lung cancer: a prospective cohort study Junjie Meng, Jinrong Wu, Qiang Li · 2026

LIQUID BIOPSY ADVANCES: TRANSFORMING CANCER DIAGNOSIS AND MANAGEMENT Kondumahanti Venkata Naga Lakshmi1*, Mohammad johaparvaz2, Devanaboyina Narendra3 · 2026

Molecular Features of Gastrointestinal Stromal Tumors: A Single Referral Cancer Center Experience Angela Zupa, Giulia Vita, Alfredo Tartarone, Ludmila Carmen Omer, Giovanni Calice · 2026

Natural language processing (NLP) to identify neoplastic fever in the electronic medical record (EMR). Martin Juarez-Alvarado, Luke B. Davis, Clara Becker, Monica Gerber, Vivek Sriram · 2026

Appendiceal cancer: Historical trends in histological composition and cause-specific mortality based on SEER database analysis. J Qiqieh, Cameron Peres, Essam Al-Snayyan, Avery Mendelson, Susan E. Lyons · 2026

Mapping the association between federal AI investment and clinical validation in oncology: A multi-source ecosystem analysis. Tuan Vinh, Julie Ying Zhang, Anvi Anand, Huy Pham, Chenyu Sun · 2026

Primary Breast Angiosarcoma: A Report of a Rare Case Chalent Alexakis, Annezo Marinatou, Evgenia Kalogridaki, Eftychia Katagi, Panagiotis Daskalakis · 2026

Balancing Oncologic Safety and Fertility: A Case of Borderline Ovarian Tumor Elene Lipartia, Beka Metreveli, Natia Marghishvili, David Gagua, Tinatin Gagua · 2026

Abdominal Desmoplastic Small Round Cell Tumour: Two Clinical Cases Miguel Catalo, Catarina Macedo, Cátia Sousa, João Vitor Silva, Mariana Afonso · 2026

Analytical validation of a plasma-based cfDNA NGS assay (Guardant360 Liquid CDx) for comprehensive solid tumor profiling. Brett Kennedy, Xianxian Liu, Jessica Kurata, Ankit Jambusaria, Krishnalekha Datta · 2026

Distinct epigenetic alterations and accelerated mitotic aging define second primary breast cancers Andrés F. Bedoya-López, Javier I. J. Orozco, Pere Llinàs‐Arias, Miquel Ensenyat-Méndez, Betsy J. Valdez · 2026

Imaging features of lung cancer with cystic airspaces: clinical utility, challenges, and perspectives Mengyue Hu, Jinbao Feng, Xiaonan Shao, Y Q Shi, Jianxiong Gao · 2026

Down-regulation of PAX3 gene expression in rhabdomyosarcoma and melanoma Ahmed Abdallah Mashud · 2026

Potential new targets for rheumatic diseases Juergen Braun, Falk Hiepe · 2026

Prognostic Factors of Chinese Non-small Cell Lung Cancer Patients Receiving Best Supportive Care Joyce May Sum Leung, Ho Ming Cheung, Kwok Sing Ng · 2026

Neoadjuvant chemo-immunotherapy and surgical resection in locally advanced non-small cell lung cancer with N3 lymph node involvement (NEO-SURG). Joshua E. Reuss, Chul Kim, Cristina Merkhofer, Ece Cali, Hyein Jeon · 2026

Timing of adjuvant nivolumab and survival outcomes in bladder cancer: A real-world analysis. Kok Hoe Chan, Muhammad Yousaf, Y. Thakkar, J Collins, Amir Kamran · 2026

Real-world biomarker testing rates, targeted therapy use, and clinical outcomes in patients with advanced gastric or GEJ cancer in the United States. Lauren Damato, Noelle Liao, Jonathan Bryan, Eunice Adhiambo Hankinson, Emily Castellanos · 2026

Immune-mediated toxicities (irAEs) in immune checkpoint inhibitor (ICI) therapy in various combinations: A real-world sample. Olivia Wilkins, Alex Márki, Ethan Diamond, Karla Zamudio, Kanchi Krishnamurthy · 2026

Neoadjuvant almonertinib followed by chemo-immunotherapy in II-IIIb EGFR-mutant NSCLC: A single arm, phase II study (NEOVADE). Jun‐Tao Lin, C J Zhang, Lixu Yan, Xue−Ning Yang, Song Dong · 2026

A retrospective real-world study on the efficacy and safety of anlotinib in combination with immunotherapy as maintenance therapy after standard immunochemotherapy for extensive-stage small cell lung cancer (ALTER-L059). Yong Fang, Lei Pan, Xin Gan, Junzhen Gao, Baimei He · 2026

Real-world efficacy and safety of bispecific antibody ivonescimab-based regimens in EGFR-TKI–resistant advanced NSCLC. Chuang Yang, Wen Zhao, Minjun Rong, Huandie Qi, Rongyu Zhang · 2026

Overall survival of patients with mucosal melanoma in the US before and after the advent of PD-1 based immune checkpoint inhibitor treatment. Olivia First, Maaike van Gerwen, Seungjun Ahn, Ronit Sethi, Alexander Shoushtari · 2026

Primary adrenal insufficiency in patients with bilateral adrenal metastases treated with curative ablative radiation therapy: A comprehensive review of literature and expert agreements for radiation practice Alexander Bennassi, Kamel Debbi, Nicolas Giraud, Lahcène Belaïdi, Anna Durigova · 2026

Gastric cancer and pleomorphic liposarcoma: A Case Report of synchronous dual primary malignancies Tingting Hui, Lixia Lin, Z Yang · 2026

Epithelial‐Myoepithelial Carcinoma of Minor Salivary Glands of the Palate: A Systematic Review Nour M. Khattab, Raphaël Seveyrat, Ihsène Taihi · 2026

Preoperative lung immune prognostic index (LIPI) predicts postoperative outcomes in clear cell renal cell carcinoma: a multicenter study Zhenliang Pan, Yi Li, Jie Lou, Shuai Shan, Yusheng Guo · 2026

A Genomic and Epigenetic Comparative Study of Low-grade Biphenotypic Sinonasal Sarcoma with Metachronous and Synchronous High-grade Rhabdomyosarcomatous Transformation Rayan Sibira, C. Chen, Felipe D’. Almeida Costa, Anuj Verma, Poorva Singh · 2026

Impact of Sociodemographic Factors on the Time to Initiate Breast Cancer Treatment at a High-Complexity Hospital in Porto Alegre, Brazil Pedro Marchiori Cacilhas, Daniela Dornelles Rosa, Gustavo Thomas, Karine Lorenzen Molina, Pedhro Lennon Cezário Freitas · 2026

The Possible Role of Incompatible Dentures in Oral Squamous Cell Carcinoma: A Case Series İlknur Eninanç, Aslıhan Şahan Keskin · 2026

Integrating network pharmacology with ex-vivo analysis to assess the effect of IL-2 in halting breast cancer: involvement of Treg/CTLA-4/Blimp-1/caspase-3 Seham Abou Shousha, Sherihan Salaheldin Abdelhamid Ibrahim, Hend Kadry, Eman A. Youssef, Yasmine qabany · 2026

Important Advances in Adrenal Pathologic Classification, Imaging Analysis, and Systemic Therapy: What the Contemporary Endocrine Surgeon should Know Jennine Weller, Eddy P. Lincango, Jennifer J. Butler, Ahmed Salem, Khaled M. Elsayes · 2026

Personalized neoadjuvant treatment regimen selection in locally advanced rectal cancer based on regimen-specific response modeling X M Liu, Y D Tang, Song Zhang, Haiyang Bian, Hanlin Shu · 2026

Organoids in Cancer Research: Current Applications, Limitations, and Technological Advances Sujeong Kim, S M Park, Chanwoo Kim, Jae Yeon Kim, Sang Hyeon Han · 2026

Decoding cellular population dynamics through mechanistic modelling and statistical data analysis Nissrin Alachkar, Nicholas Kwasi-Do Ohene Opoku, Nick Monk, Kevin Thurley · 2026

A foundation model of cancer genotype enables precise predictions of therapeutic response JungHo Kong, Ingoo Lee, Dean Boecher, Akshat Singhal, Marcus R. Kelly · 2026

Tumor genome and microenvironment alteration by trastuzumab deruxtecan as neoadjuvant therapy for HER2-mutant NSCLC Jiangyang Li, Xianfeng Lu, Shuai Yue, Ruyi Hang, Xiaoyan Dai · 2026

Transcriptomic analysis of genes in bladder cancer patients with resistance to neoadjuvant chemoimmunotherapy C Chen, Xincheng Liu, Abai Xu, Ning Jiang, Peng Wang · 2026

xCELLigence™ RTCA system in cancer biology: innovations in real-time functional profiling Charlene Andraos, Jitcy S. Joseph, Wells Utembe, Millicent Magogotya, Olumayowa Oriyomi · 2026

Pembrolizumab versus Ipilimumab in Advanced Melanoma Caroline Robert, Jacob Schachter, Georgina V. Long, Ana Arance, Jean‐Jacques Grob · 2015

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer H. Borghaei, L. Paz-Ares, Leora Horn, David R. Spigel, Martin Steins · 2015

SNORD50A/B disassemble ASC-1 complex to silence NF-κB and boost PD-1 blockade in non-small-cell lung cancer Jingjing Ma, Qingyuan He, Jun Pu, Ying Liu, Xiao Cui · 2026

The silent pharmacist: Harnessing the gut microbiome to improve therapy in hematologic malignancies Amr Ali Mohamed Abdelgawwad El-Sehrawy, Hamed Soleimani Samarkhazan · 2026

Psychological distress following immune checkpoint inhibitor associated diabetes: a case report Stephanie Saey, Jas Sara, Pankaj Shah · 2026

Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer: A Literature Overview Anita Gorzelak-Magiera, Jacek Kabut, Joanna Sadurska, Anna Długaszek, Małgorzata Domagała-Haduch · 2026

Overcoming Tumor Hypoxia in Photodynamic Therapy: A Comprehensive Review of Oxygen-Delivery Carriers and Type I Photosensitizers Dorota Bartusik-Aebisher, Izabela Rudy, Kacper Rogóż, Jakub Szpara, Aleksandra KAWCZYK-KRUPKA · 2026

Cracking the shield: oncolytic viruses versus the tumor-immune fortress Azza M. El-Derby, Nouran T. Salem, Noha Hesham, Tamer Z. Salem · 2026

Targeting the SOX11/GPX4/SLC7A11 Axis: A Novel Mechanism for Boric Acid-Induced Ferroptosis in Endometrial Cancer Elif Karabacak, Ceyhan Hacıoğlu · 2026

The STK11 gene F354L mutation is associated with male spermatogenic dysfunction Neng Wan, Xiang Huang, Gang Jing, Laifeng Ren · 2026

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos · 2017

Primary Pulmonary Epithelioid Inflammatory Myofibroblastic Sarcoma With <scp>SQSTM1</scp> :: <scp>ALK</scp> Fusion Havva Gökce Terzioglu, Phillip McMullen, Güliz A. Barkan · 2026

RNA splicing in cancer cell death regulation: shedding light on the molecular mechanisms and potential clinical applications Minghui Song, Yaru Wang, Haiyun Zhang, Xinyu Ji, Shuqing Sun · 2026

Reprogramming the Immune Landscape of Inflammatory Breast Cancer Verena Martinez‐Rodriguez, Suguru Ogata, Xiaoping Wang, Naoto T. Ueno · 2026

An Unusual Infectious Cause of Abdominal Pain: Non-typhoidal Salmonella Aortitis Complicating an Endovascular Aortic Stent Graft Elodie E Baumgartner, Lexi Weltin, John P Whitten, Timothy E. Fahey, Peter B Baumgartel · 2026

Outcomes of Patients with RET Fusion-Positive Non-Small Cell Lung Cancer Treated with First-Line Non-Molecularly Targeted Therapies: A Real-World Benchmark in Europe from the RECALIB-RET Study Luis León‐Mateos, M. Hochmair, Amparo Sánchez-Gastaldo, Audrey Rabeau, J.B. Auliac · 2026

Temperature-sensitive liquid embolic agent loaded with Lobaplatin in the TACE procedure for rabbit VX2 liver tumor Yahua Li, J F Chen, J J Zhang, Zongming Li, Yifan Zhang · 2026

SCRUM-Japan MONSTAR3 hematology cohort: a nationwide multi-omics integrated platform for next-generation precision medicine in hematologic malignancies Kensuke Matsuda, Junichiro Yuda, Ryo Yoshimaru, Isamu Harima, Hajime Sakuma · 2026

Isolated Psoas Muscle Metastasis From Ampullary Carcinoma: A Report of a Rare Case Fábio Viveiros, Nereida Monteiro, Conceição Monteiro, Cristina Monteiro, Rui Escaleira · 2026

EpCAM-targeted ZIF-8 nanocarriers for enhanced doxorubicin delivery in cancer therapy: a promising approach for tumor-specific drug release Mojtaba Tarin, Yazdan Hasani-Nourian, Hosein Khoshsafar, Hasan Bagheri · 2026

Oncology Reimagined: Treating Cancer Through Digital Twins Hossein Rezazadeh, Erfan Fakouri, Ali Madadimahani, Ali Hajghani, Saeed Afsharmanesh · 2026

A phase 1 study of PF-07260437, a B7-H4 × CD3 bispecific T-cell engager, in patients with advanced or metastatic breast, ovarian, and endometrial cancer Fengting Yan, Marcia Cruz-Correa, Jennifer Specht, Edward Wenge Wang, Jinyu Lu · 2026

The Paradigm Shift in Clinical Stage II Non-Small-Cell Lung Cancer Management: A Comprehensive Review of Optimal Surgical and Systemic Approaches Tyler W. Wilson, Jessica S. Donington · 2026

Durable remission despite transplantation with active disease in therapy-related NUP98::TOP1-rearranged acute myeloid leukemia Gaetano Cimino, Rebecca Sembenico, Francesco Zorutti, Simonetta Saldi, Matteo Caridi · 2026

The skin check of the future: improving early detection of melanoma while avoiding overdiagnosis Susan M. Swetter, Sancy A. Leachman, Raymond L. Barnhill, Laura K. Ferris, Allan C. Halpern · 2026

Now or Later? Defining the Ideal Time for Surgical Cytoreduction in Advanced Ovarian Cancer Kristin Bixel, Alexander Olawaiye, Margaret Flanigan, Paulina Haight, Sven Mahner · 2026

Prevalence and its associated factors of cancer-related fatigue among liver cancer patients: a cross-sectional study Xuejiao Xiong, Qian Wang, (Leona) Li Wang, Biying Fu, Min Tu · 2026

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas · 2016

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw, Richard Aplenc, David M. Barrett · 2014

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer Philip W. Kantoff, Celestia S. Higano, Neal D. Shore, E. Roy Berger, Eric J. Small · 2010

Misdiagnosis of Endometrioid Borderline Ovarian Tumors by Intraoperative Frozen Section Pathology: A Case Report and Review of the Literature Huifen Wang, Hongqin Du · 2026

Budget impact analysis of Oncotype DX® multigenic prognostic test in patients with early breast cancer in Italy Oriana Ciani, Carlo Federici, Daniele Generali, Alberto Zambelli · 2026

Risk Factors for 30-Day Hospital Readmission in Patients With Cancer: A Systematic Review With Emphasis on Older Adults Godswill O Nwabor, Noor Subhani, Desire Weke, Reigneth C Obianenue, Happiness Olaniyi · 2026

An Intriguing Case of Chemical Mimicry: Raised AFP Levels in NUT Carcinoma in Anterior Mediastinum Manasi Mundada, Daphne Fonseca, Faiq Ahmed, Suseela Kodandpani, Nikhil Pathi · 2026

Beckwith-Wiedemann syndrome multiomic analysis of hepatoblastoma uncovers unique tumour heterogeneity and cellular landscapes, including transition cells leading to tumour formation Snehal Nirgude, Elisia D. Tichy, Yuanchao Zhang, Khanh B. Trang, Rose D. Pradieu · 2026

Integrated genomic analyses of ovarian carcinoma Debra Bell, Andrew Berchuck, Andrew Berchuck, Michael J. Birrer, Marcin Imieliński · 2011

Cancer statistics, 2024 Rebecca L. Siegel, Angela N. Giaquinto, Ahmedin Jemal · 2024

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Jürgen Thiele, Michael J. Borowitz · 2016

The Potential and Challenges of Focused Ultrasound-Mediated Therapies in the Management of Liver and Biliary Tract Cancers Mira Florea, Viorica Nagy, Paul Milan Kubelac, Adrian Bartos, Delia Dima · 2026

Definitive radiotherapy for non-small-cell lung cancer: current practice and future directions Noriko Kishi, Tomoki Kimura, Takashi Mizowaki · 2026

Impact of social determinants of health on treatment patterns and outcomes in metastatic non-small cell lung cancer Nathan R. Hill, Amanda Crosbie, Rick Szymialis, Afraim Botros, Ying Zhang · 2026

Prognostic and Treatment-Associated Survival Effects of Microsatellite Instability Across Disease Stages in Colon Cancer: An NCDB Analysis Mohyeddine El Sayed, Sassine Youssef, Maha Chaccour, Melhem El Harati · 2026

Umbilical cord blood-derived natural killer cells: in vitro, in vivo, and clinical antitumor activity in non-small cell lung cancer (case series) Zhi lan Zhang, Qing Wu, Jiabin Chen, Ze Lin Zhao, Zhiqiang Cheng · 2026

ROLE OF BACILLUS CALMETTE–GUÉRIN (BCG) IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) Khadka Ravi Roshan · 2026

Atypical Gastrointestinal Kaposi Sarcoma With Circumferential Anorectal Involvement in a Young Man With Controlled HIV Infection: A Case Report Maria H Garcia Ramírez, Laura B Alegría López, Isac I Ramírez-Preciado, Luis A Villalobos Calderon, Juan G García González · 2026

Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy Michael Schneider, Luca Paruzzo, Federico Stella, Julia Han Noll, Matthew Ho · 2026

Bridging the gap: a systematic literature review and meta-analysis on the management of rectal wall defect after transanal excision S. Vaghiri, E. Gorgun, H. Kessler, W. T. Knoefel, D. Prassas · 2026

Potential medical applicability of N-β-Ala and N-His dipeptidomimetics against breast cancer: short in vitro and in silico screening Klaudia Chmielewska, Justyna Budka, Katarzyna Kozłowska-Tylingo, Iwona Inkielewicz‐Stępniak, Krystyna Dzierzbicka · 2026

Platelet FcɣRIIa: a novel biomarker of risk for thromboembolism and death in cancer Chris E. Holmes, George A. Davis, Heidi S. Taatjes‐Sommer, Naomi E. Sai-Hardebeck, Peter Callas · 2026

Targeting EHMT2 overcomes 5-fluorouracil resistance in colorectal cancer by modulating cell cycle and apoptosis In Hwan Tae, Yunsang Kang, Jinkwon Lee, Jeong Min Lee, Jinsan Kim · 2026

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel Hartmut Döhner, Elihu H. Estey, David Grimwade, Sergio Amadori, Frederick R. Appelbaum · 2016

The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS) Bjoern Menze, András Jakab, Stefan Bauer, Jayashree Kalpathy–Cramer, Keyvan Farahani · 2014

Comprehensive molecular characterization of gastric adenocarcinoma Adam J. Bass, Natalie Tasman, Brady Bernard, Vésteinn Thórsson, Roger Kramer · 2014

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation Paul B. Chapman, Axel Hauschild, Caroline Robert, John B.A.G. Haanen, Paolo A. Ascierto · 2011

TRIM28-mediated SUMOylation of SREBF1 drives PD‑L1 N‑glycosylation and immune evasion in bladder cancer Ru Chen, Y.-F. Su, Jianhui Chen, Shaoxing Zhu, Xiaobao Chen · 2026

Estimation of split renal function on PET using the SSTR-targeting radioligands [18F]SiTATE, [68Ga]Ga-DOTA-TATE and [68Ga]Ga-DOTA-TOC in a theranostic setting Maximilian Tiling, Lena M. Unterrainer, Sophie C. Siegmund, J. Zahner, Zachary Ells · 2026

Dysphagia Secondary to Extrinsic Esophageal Compression From an Anterior Mediastinal Squamous Cell Carcinoma Alireza Izadian Bidgoli, Alberto Gomez Veliz · 2026

Management of advanced sporadic endolymphatic sac tumours: a single-centre case series N. Rajendram, N.A. O'Keeffe, J. Garry, H. Barrett, S. Looby · 2026

Systemic Therapy for Solitary Fibrous Tumor Georgios M. Stergiopoulos, Gabriel Tinoco, Steven I. Robinson · 2026

CHIP clinics: a practical overview of structure and function Shyam A. Patel, Abhishek A. Mangaonkar · 2026

Biological activities and therapeutic potential of soy isoflavones: a focus on anticancer activity Maciej Kwieciński, Bartłomiej Kwiatkowski, Weronika Ziomek, Weronika Bomba, Paula Wróblewska-Łuczka · 2026

Application of artificial intelligence based on contrast-enhanced CT imaging for predicting peritoneal metastasis in patients with T3/T4 stage gastric cancer Chao qun Zhang, Siyuan Li, Daolai Huang, Bo Wen, 韦世壮 · 2026

Drug-Induced Liver Injury Following Co-ingestion of Veterinary Fenbendazole and Ivermectin for Prostate Cancer: A Case Report Grace E Powderly, Kiley Hassevoort, Morgan Loy, Jamie Balonier, Corey Sievers · 2026

Balancing Efficacy and Safety in Multiple Myeloma Patients Receiving B cell Maturation Antigen–Directed CAR T-Cell Therapy Maria T. Kuipers, Jorne Migchelbrink, Anne Marijn Kramer, Mathilde C.M. Kouwenhoven, Sonja Zweegman · 2026

Navigating Immunotherapy in a Kidney Transplant Recipient: A Case Report of POLE-Mutated Jejunal Adenocarcinoma Gabriela Carrillo, Megan Sharp, Madhumita Baskaran, Kavya Avancha, Rami P Atallah · 2026

Identification of 2-(piperazine _1_yl) _H_benzo[d] imidazole derivatives as a potent EGFR inhibitor by Virtual Screening and Molecular Dynamic Simulation Sarah Badri Jasim, Amani Amer Tawfeeq, Wathiq Al-hachami, Monther Faisal · 2026

An Unusual Destination: Neuroendocrine Carcinoma Arising in the Breast, an Uncommon and Aggressive Entity Hanan Bailal, Fadoua Jebrouni, Kaouthar Khater, Asmae Bali, Hind Chibani · 2026

Nano-engineered precision strategies for hematological malignancies: current advances and translational roadmap Zhongsong Zhang, Junhao Chen, Qi Shi, Zihan Zhou, B Wang · 2026

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010 Quinn T. Ostrom, Haley Gittleman, P Farah, A. Ondracek, Yaning Chen · 2013

Comprehensive molecular portraits of human breast tumours The Cancer Genome Atlas Network · 2012

Cancer statistics, 2023 Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle, Ahmedin Jemal · 2023

ПОГРАНИЧНЫЕ ОПУХОЛИ ЯИЧНИКОВ Давыдова И. Ю., Валиев Р. К., Карселадзе А. И., Ашрафян Л. А., Новикова Е. Г., и др. · 2023

СОЛИДНЫЕ ОПУХОЛИ НА ФОНЕ БЕРЕМЕННОСТИ Стенина М. Б., Пароконная А. А., Полушкина Е. С., Ульрих Е. А., Хохлова С. В., и др. · 2023

РЕДКИЙ СЛУЧАЙ СОЛИТАРНОЙ ФИБРОЗНОЙ ОПУХОЛИ МАЛОГО ТАЗА Петров Л. О., Головков Д. А., Мошуров Р. И., Малев С. С., Феденко А. А. · 2023

Эпителиоидная трофобластическая опухоль — редкая опухоль, ассоциированная с беременностью Мещерякова Л. А., Гиголаева Н. М., Мещеряков О. А. · 2023

Опухоли. Новообразования. Бластомы. Хористомы. Гамартомы. Онкология